A survey of adults with obesity from six Western European countries highlights the struggle people with obesity endure trying to lose weight, and sheds new light on what works and what doesn't when it comes to losing weight.
May 4, 2022
0
29
An estimated 25 percent of people older than 65 have type 2 diabetes, a condition in which the body cannot produce enough insulin to effectively manage blood sugar. Insulin plays an important role in the brain, and people ...
Apr 29, 2022
1
111
Rates of atrial fibrillation (AF) recurrence following ablation increase incrementally according to body mass index, both in short- and long-term follow-up, according to a study presented at the annual meeting of the European ...
Apr 5, 2022
0
26
Acute kidney injury (AKI) is a common complication of COVID-19 and is associated with a higher risk of death. A new study published in CJASN has examined the use of palliative care in patients with COVID-19 and AKI.
Feb 24, 2022
0
4
(HealthDay)—Among adults with overweight or obesity, once-weekly subcutaneous semaglutide plus counseling for diet and physical activity results in significantly greater weight loss at 68 weeks than once-daily subcutaneous ...
Jan 21, 2022
0
50
A new study led through a collaboration between the Diabetes Trials Unit and the Department of Psychiatry at the University of Oxford, and the global healthcare company, Novo Nordisk, will examine whether semaglutide, a tablet ...
Dec 10, 2021
0
17
The burden of diabetes is increasing globally. There are about half a billion people in the world living with the disease. In sub-Saharan Africa, 23 million people had diabetes in 2021. This number is expected to increase ...
Nov 22, 2021
0
53
(HealthDay)—For adults with diabetes, cycling is associated with reduced all-cause and cardiovascular disease (CVD) mortality, according to a study published online July 19 in JAMA Internal Medicine.
Jul 20, 2021
0
3
Walmart said Tuesday that it will start selling its own private brand of insulin at much lower prices than competing products.
Jun 29, 2021
0
4
Regulators on Friday said a new version of a popular diabetes medicine could be sold as a weight-loss drug in the U.S.
Jun 4, 2021
0
27
